The Conversation (0)
Protea Biosciences Group, Inc. (OTCQB:PRGB) has partnered with Protein Metrics Inc.to advance new analytical capabilities for use in the development of protein biotherapeutics.
Protea Biosciences Group, Inc. (OTCQB:PRGB) has partnered with Protein Metrics Inc.to advance new analytical capabilities for use in the development of protein biotherapeutics.
According to Greg Kilby, Ph.D., Protea’s Vice President and Chief Operating Officer:
Our Protein Metrics collaboration will provide Protea access to advanced software for comprehensive protein characterization, PTM analysis, and sequence variant analysis. We will combine our technologies, including our proprietary LAESI mass spec imaging platform, with Protein Metrics software to provide novel, ‘big data’ services to identify, characterize, and quantify biologically important molecules. Biopharma is in need of these new bioanalytical capabilities.